Cerebral and Tissue Oximetry Device Market - Top Companies and Manufacturers

  • Report ID: 5837
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the Cerebral and Tissue Oximetry Landscape

    • Artinis Medical Systems
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Edwards Lifesciences Corp.
    • Hamamatsu Photonics KK
    • HyperMed Imaging Inc.
    • Brain Scientific Inc.
    • Masimo Corp.
    • Medtronic Plc
    • Moor Instruments Ltd.
    • Nihon Kohden Corporation
    • Sotera Health Co.

Browse Key Market Insights with Data Illustration:

In the News

  • The acquisition of Brain Scientific, a company specialising in cerebral oximetry monitoring, was announced by Masimo, a global leader in pulse oximetry and patient monitoring technology, in November 2023. This step will reinforce Masimo's position on the market for brain monitoring and broaden its range of non-invasive detection technologies.
  • BrainOx, a medical technology company specialising in cerebral oximetry systems and Nihon Kohden, the leading manufacturer of medical devices, signed an agreement to develop and market solutions for monitoring cerebral oximetry on August 23, 2023. This collaboration with Nihon Kohdens' experience in the production and distribution of medical devices aims to take advantage of BrainOx expertise on brain oximetry technology.

Author Credits:  Radhika Pawar


  • Report ID: 5837
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cerebral and tissue oximetry device is estimated at USD 249.2 million.

Cerebral and Tissue Oximetry Device Market size was valued at USD 237.06 million in 2024 and is set to cross USD 531.01 million by the end of 2037, expanding at more than 6.4% CAGR during the forecast period i.e., between 2025-2037. The growing technological advancement and increasing collaboration for research and development will drive the market growth.

North America industry is anticipated to hold largest revenue share of 35% by 2037, due to rising substantial prevalence of cardiovascular disease in the region.

The major players in the market are of Brain Scientific Inc., Masimo Corp., Medtronic Plc, Moor Instruments Ltd., Nihon Kohden Corporation, Sotera Health Co., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample